Symbols / OBIO $4.23 -2.76% Orchestra BioMed Holdings, Inc.

Healthcare • Biotechnology • United States • NGM
OBIO Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 263.93M Enterprise Value Income Sales Book/sh Cash/sh
Dividend Yield Payout Employees IPO P/E Forward P/E
PEG P/S P/B P/C EV/EBITDA EV/Sales
Quick Ratio Current Ratio Debt/Eq LT Debt/Eq EPS (ttm) EPS next Y
EPS Growth Revenue Growth Earnings ROA ROE ROIC
Gross Margin Oper. Margin Profit Margin Shs Outstand Shs Float Short Float
Short Ratio Short Interest 52W High 52W Low Beta Avg Volume
Volume Target Price Recom Prev Close $4.35 Price $4.23 Change -2.76%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
33.48
+1169.22%
2.64
-4.42%
2.76
-21.88%
3.53
Operating Revenue
33.48
+1169.22%
2.64
-4.42%
2.76
-21.88%
3.53
Cost Of Revenue
0.19
-6.86%
0.20
+9.68%
0.19
-11.85%
0.21
Reconciled Cost Of Revenue
0.19
-6.86%
0.20
+9.68%
0.19
-11.85%
0.21
Gross Profit
33.29
+1267.79%
2.43
-5.44%
2.57
-22.52%
3.32
Operating Expense
85.10
+27.52%
66.73
+23.40%
54.08
+50.31%
35.98
Research And Development
58.19
+35.93%
42.80
+26.56%
33.82
+54.12%
21.95
Selling General And Administration
26.91
+12.47%
23.93
+18.13%
20.26
+44.35%
14.03
Total Expenses
85.29
+27.41%
66.94
+23.35%
54.27
+49.95%
36.19
Operating Income
-51.81
+19.43%
-64.30
-24.84%
-51.51
-57.72%
-32.66
Total Operating Income As Reported
-51.81
+19.43%
-64.30
-24.84%
-51.51
-57.72%
-32.66
EBITDA
-51.23
+19.95%
-63.99
-24.94%
-51.22
-57.91%
-32.44
Normalized EBITDA
-51.48
+19.47%
-63.92
-28.48%
-49.76
-58.29%
-31.43
Reconciled Depreciation
0.33
+6.17%
0.31
+7.32%
0.29
+29.28%
0.22
EBIT
-51.55
+19.83%
-64.30
-24.84%
-51.51
-57.72%
-32.66
Total Unusual Items
0.25
+473.53%
-0.07
+95.35%
-1.46
-46.15%
-1.00
Total Unusual Items Excluding Goodwill
0.25
+473.53%
-0.07
+95.35%
-1.46
-46.15%
-1.00
Special Income Charges
0.00
+100.00%
-1.15
-68.77%
-0.68
Other Special Charges
1.15
+68.77%
0.68
Net Income
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Pretax Income
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Net Non Operating Interest Income Expense
-1.15
-134.21%
3.36
-12.81%
3.85
+7598.00%
0.05
Interest Expense Non Operating
1.15
Net Interest Income
-1.15
-134.21%
3.36
-12.81%
3.85
+7598.00%
0.05
Interest Expense
1.15
Interest Income Non Operating
3.36
-12.81%
3.85
+7598.00%
0.05
Interest Income
3.36
-12.81%
3.85
+7598.00%
0.05
Other Income Expense
0.25
+421.52%
-0.08
+94.60%
-1.46
-46.15%
-1.00
Other Non Operating Income Expenses
-0.01
Gain On Sale Of Security
0.25
+473.53%
-0.07
+78.21%
-0.31
+2.19%
-0.32
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Net Income From Continuing Operation Net Minority Interest
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Net Income From Continuing And Discontinued Operation
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Net Income Continuous Operations
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Normalized Income
-52.95
+13.13%
-60.96
-27.91%
-47.66
-46.16%
-32.61
Net Income Common Stockholders
-52.95
+13.22%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Diluted EPS
-1.66
-12.16%
-1.48
-39.22%
-1.06
Basic EPS
-1.66
-12.16%
-1.48
-39.22%
-1.06
Basic Average Shares
36.82
+10.82%
33.23
+5.10%
31.61
Diluted Average Shares
36.82
+10.82%
33.23
+5.10%
31.61
Diluted NI Availto Com Stockholders
-52.95
+13.22%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Preferred Stock Dividends
0.25
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
114.86
+50.78%
76.17
-20.00%
95.21
-0.38%
95.57
Current Assets
107.91
+56.01%
69.17
-22.38%
89.11
+5.22%
84.69
Cash Cash Equivalents And Short Term Investments
106.51
+59.42%
66.81
-23.73%
87.59
+4.55%
83.78
Cash And Cash Equivalents
34.69
+55.83%
22.26
-27.15%
30.56
+54.46%
19.78
Other Short Term Investments
71.82
+61.21%
44.55
-21.89%
57.04
-10.88%
64.00
Receivables
0.10
+3.26%
0.09
-7.07%
0.10
+3.13%
0.10
Accounts Receivable
0.10
+3.26%
0.09
-7.07%
0.10
+3.13%
0.10
Inventory
0.31
+79.19%
0.17
+18.49%
0.15
-47.10%
0.28
Prepaid Assets
Other Current Assets
0.99
-52.53%
2.09
+64.36%
1.27
+139.02%
0.53
Total Non Current Assets
6.95
-0.80%
7.00
+14.82%
6.10
-43.96%
10.88
Net PPE
3.21
-7.92%
3.49
+23.04%
2.83
-22.91%
3.68
Gross PPE
4.84
+1.09%
4.79
+23.52%
3.88
-12.93%
4.45
Accumulated Depreciation
-1.63
-25.17%
-1.30
-24.81%
-1.04
-34.19%
-0.78
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.44
+0.00%
0.44
+29.45%
0.34
-5.77%
0.36
Construction In Progress
Other Properties
4.24
+1.24%
4.19
+25.66%
3.33
-14.54%
3.90
Leases
0.16
+0.00%
0.16
-21.67%
0.20
+6.28%
0.19
Investments And Advances
2.50
+0.00%
2.50
+0.00%
2.50
+0.00%
2.50
Non Current Prepaid Assets
Other Non Current Assets
1.24
+21.57%
1.02
+32.64%
0.77
-83.68%
4.71
Total Liabilities Net Minority Interest
61.29
+41.82%
43.22
+59.06%
27.17
-36.87%
43.04
Current Liabilities
16.74
+3.26%
16.21
+44.60%
11.21
-39.63%
18.57
Payables And Accrued Expenses
11.82
+37.40%
8.61
+59.73%
5.39
-21.50%
6.86
Payables
6.09
+18.72%
5.13
+77.03%
2.90
-26.92%
3.97
Accounts Payable
6.09
+18.72%
5.13
+77.03%
2.90
-26.92%
3.97
Current Accrued Expenses
5.73
+65.03%
3.47
+39.55%
2.49
-14.09%
2.90
Pensionand Other Post Retirement Benefit Plans Current
4.16
+59.26%
2.61
-1.84%
2.66
+7.30%
2.48
Total Tax Payable
Current Debt And Capital Lease Obligation
0.75
+36.55%
0.55
-15.25%
0.65
-6.89%
0.70
Current Debt
Other Current Borrowings
Current Capital Lease Obligation
0.75
+36.55%
0.55
-15.25%
0.65
-6.89%
0.70
Current Deferred Liabilities
0.00
-100.00%
4.44
+76.85%
2.51
-61.00%
6.44
Current Deferred Revenue
0.00
-100.00%
4.44
+76.85%
2.51
-61.00%
6.44
Other Current Liabilities
2.09
Total Non Current Liabilities Net Minority Interest
44.55
+64.95%
27.01
+69.21%
15.96
-34.78%
24.47
Long Term Debt And Capital Lease Obligation
15.20
-4.85%
15.98
+1439.40%
1.04
-90.71%
11.17
Long Term Debt
14.27
-0.17%
14.29
9.49
Long Term Capital Lease Obligation
0.94
-44.52%
1.69
+62.52%
1.04
-38.32%
1.68
Non Current Deferred Liabilities
0.00
-100.00%
10.99
-26.36%
14.92
+13.89%
13.10
Non Current Deferred Revenue
0.00
-100.00%
10.99
-26.36%
14.92
+13.89%
13.10
Other Non Current Liabilities
16.79
+41875.00%
0.04
0.20
Preferred Securities Outside Stock Equity
9.81
0.00
Stockholders Equity
53.57
+62.54%
32.96
-51.56%
68.04
+29.52%
52.53
Common Stock Equity
53.57
+62.54%
32.96
-51.56%
68.04
+29.52%
52.53
Capital Stock
0.01
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Common Stock
0.01
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
57.03
+49.32%
38.19
+6.76%
35.78
+13.17%
31.61
Ordinary Shares Number
57.03
+49.32%
38.19
+6.76%
35.78
+13.17%
31.61
Additional Paid In Capital
416.08
+21.38%
342.78
+8.17%
316.90
+25.62%
252.27
Retained Earnings
-362.58
-17.01%
-309.88
-24.52%
-248.85
-24.59%
-199.73
Gains Losses Not Affecting Retained Earnings
0.06
+15.38%
0.05
+620.00%
-0.01
-25.00%
-0.01
Other Equity Adjustments
0.06
+15.38%
0.05
+620.00%
-0.01
-25.00%
-0.01
Total Equity Gross Minority Interest
53.57
+62.54%
32.96
-51.56%
68.04
+29.52%
52.53
Total Capitalization
67.84
+43.57%
47.25
-30.56%
68.04
+9.70%
62.02
Working Capital
91.17
+72.15%
52.96
-32.02%
77.91
+17.82%
66.12
Invested Capital
67.84
+43.57%
47.25
-30.56%
68.04
+9.70%
62.02
Total Debt
15.96
-3.47%
16.53
+879.79%
1.69
-85.79%
11.87
Capital Lease Obligations
1.69
-24.59%
2.24
+32.60%
1.69
-29.12%
2.38
Net Tangible Assets
53.57
+62.54%
32.96
-51.56%
68.04
+29.52%
52.53
Tangible Book Value
53.57
+62.54%
32.96
-51.56%
68.04
+29.52%
52.53
Derivative Product Liabilities
2.75
0.00
Investmentin Financial Assets
2.50
+0.00%
2.50
+0.00%
2.50
+0.00%
2.50
Trading Securities
2.50
+0.00%
2.50
+0.00%
2.50
+0.00%
2.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-48.96
+3.15%
-50.56
-9.61%
-46.13
-57.49%
-29.29
Cash Flow From Continuing Operating Activities
-48.96
+3.15%
-50.56
-9.61%
-46.13
-57.49%
-29.29
Net Income From Continuing Operations
-52.70
+13.64%
-61.02
-24.23%
-49.12
-46.16%
-33.61
Depreciation Amortization Depletion
0.33
+6.17%
0.31
+7.32%
0.29
+29.28%
0.22
Depreciation And Amortization
0.33
+6.17%
0.31
+7.32%
0.29
+29.28%
0.22
Other Non Cash Items
2.06
+757.92%
0.24
+107.80%
-3.08
-2394.78%
0.13
Stock Based Compensation
11.98
+12.84%
10.62
+39.21%
7.62
+123.41%
3.41
Operating Gains Losses
-0.25
1.45
-28.89%
2.03
Gain Loss On Investment Securities
-0.25
0.29
-78.22%
1.35
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
0.07
+277.78%
0.02
+101.75%
-1.03
Change In Working Capital
-10.37
-1255.82%
-0.77
+76.87%
-3.31
-633.26%
-0.45
Change In Receivables
-0.00
-113.64%
0.02
+833.33%
-0.00
-112.00%
0.03
Changes In Account Receivables
-0.00
-113.64%
0.02
+833.33%
-0.00
-112.00%
0.03
Change In Inventory
-0.14
-389.29%
-0.03
-121.37%
0.13
+162.98%
-0.21
Change In Prepaid Assets
0.88
+182.17%
-1.07
-37.13%
-0.78
-77.90%
-0.44
Change In Payables And Accrued Expense
4.87
+63.89%
2.97
+1947.59%
0.14
-95.67%
3.35
Change In Payable
Change In Account Payable
Change In Other Working Capital
-15.43
-669.48%
-2.00
+4.80%
-2.11
+26.42%
-2.86
Change In Other Current Liabilities
-0.55
+15.64%
-0.65
+5.92%
-0.69
-117.24%
-0.32
Investing Cash Flow
-26.94
-305.83%
13.09
+22.48%
10.69
+116.67%
-64.12
Cash Flow From Continuing Investing Activities
-26.94
-305.83%
13.09
+22.48%
10.69
+116.67%
-64.12
Net PPE Purchase And Sale
-0.49
-69.20%
-0.29
-270.51%
-0.08
+86.80%
-0.59
Purchase Of PPE
-0.49
-69.20%
-0.29
-270.51%
-0.08
+86.80%
-0.59
Capital Expenditure
-0.49
-69.20%
-0.29
-270.51%
-0.08
+86.80%
-0.59
Net Investment Purchase And Sale
-26.45
-289.21%
13.98
+29.87%
10.77
+116.94%
-63.53
Purchase Of Investment
-76.31
-5.04%
-72.65
+48.85%
-142.03
-123.56%
-63.53
Sale Of Investment
49.86
-42.44%
86.63
-43.31%
152.80
0.00
Net Other Investing Changes
-0.60
Financing Cash Flow
88.33
+202.81%
29.17
-36.88%
46.22
-55.24%
103.26
Cash Flow From Continuing Financing Activities
88.33
+202.81%
29.17
-36.88%
46.22
-55.24%
103.26
Net Issuance Payments Of Debt
0.00
-100.00%
15.00
+238.26%
-10.85
-405.26%
3.55
Issuance Of Debt
0.00
-100.00%
15.00
0.00
-100.00%
10.00
Repayment Of Debt
0.00
+100.00%
-10.85
-68.31%
-6.45
Long Term Debt Issuance
0.00
-100.00%
15.00
0.00
-100.00%
10.00
Long Term Debt Payments
0.00
+100.00%
-10.85
-68.31%
-6.45
Net Long Term Debt Issuance
0.00
-100.00%
15.00
+238.26%
-10.85
-405.26%
3.55
Net Common Stock Issuance
59.32
+294.57%
15.04
0.00
-100.00%
109.83
Proceeds From Stock Option Exercised
0.09
-62.08%
0.24
-5.51%
0.25
+33.68%
0.19
Net Other Financing Charges
16.36
+1582.07%
-1.10
-101.94%
56.81
+650.64%
-10.32
Changes In Cash
12.43
+249.78%
-8.30
-177.01%
10.78
+9.44%
9.85
Beginning Cash Position
22.26
-27.15%
30.56
+54.46%
19.78
+99.07%
9.94
End Cash Position
34.69
+55.83%
22.26
-27.15%
30.56
+54.46%
19.78
Free Cash Flow
-49.45
+2.74%
-50.85
-10.05%
-46.20
-54.64%
-29.88
Interest Paid Supplemental Data
1.45
+1318.63%
0.10
-90.88%
1.12
-18.38%
1.37
Common Stock Issuance
59.32
+294.57%
15.04
0.00
-100.00%
109.83
Issuance Of Capital Stock
71.88
+378.08%
15.04
0.00
-100.00%
109.83
Net Preferred Stock Issuance
12.56
0.00
Preferred Stock Issuance
12.56
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category